Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$161,948,948
-$1,804,940 QoQ
Shares Held
2,505,786
+3.0% QoQ
Ownership
2.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.25995276531995.ToString("F0")% Shared 0.ToString("F0")% None 0.7400472346800565.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. HALO ranks #24 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $161,948,948 2,505,786
2025-12-31 $163,753,888 2,433,193
2025-09-30 $178,310,001 2,431,279
2025-06-30 $126,539,118 2,432,509
2025-03-31 $202,229,203 3,169,240
2024-12-31 $146,493,282 3,064,072
2024-09-30 $175,161,897 3,060,131
2024-06-30 $158,610,482 3,029,230
2024-03-31 $123,153,981 3,027,384
2023-12-31 $107,914,440 2,919,763
2023-09-30 $106,476,731 2,787,349
2023-06-30 $98,480,766 2,730,268
2023-03-31 $100,492,669 2,631,387
2022-12-31 $143,109,019 2,515,097
2022-09-30 $97,935,202 2,476,864
2022-06-30 $107,478,712 2,442,698
2022-03-31 $99,960,575 2,506,534
2021-12-31 $99,502,298 2,474,566
2021-09-30 $100,031,021 2,458,973
2021-06-30 $111,101,105 2,446,622
2021-03-31 $94,521,986 2,267,258
2020-12-31 $90,878,338 2,127,800
2020-09-30 $53,690,670 2,043,024
2020-06-30 $51,216,242 1,910,341
2020-03-31 $33,884,308 1,883,508